ARTICLE | Company News
Sosei, AstraZeneca deal
July 18, 2016 7:00 AM UTC
Sosei’s Heptares Therapeutics subsidiary received a $10 million milestone payment from AstraZeneca under a 2015 deal granting AZ exclusive, worldwide rights to develop and commercialize HTL1071 ( AZD...